Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial
SB Bressler, H Qin, M Melia, NM Bressler… - JAMA …, 2013 - jamanetwork.com
Importance The standard care for proliferative diabetic retinopathy (PDR) usually is
panretinal photocoagulation, an inherently destructive treatment that can cause iatrogenic
vision loss. Therefore, evaluating the effects of therapies for diabetic macular edema on
development or worsening of PDR might lead to new therapies for PDR. Objective To
evaluate the effects of intravitreal ranibizumab or triamcinolone acetonide, administered to
treat diabetic macular edema, on worsening of diabetic retinopathy. Design Exploratory …
panretinal photocoagulation, an inherently destructive treatment that can cause iatrogenic
vision loss. Therefore, evaluating the effects of therapies for diabetic macular edema on
development or worsening of PDR might lead to new therapies for PDR. Objective To
evaluate the effects of intravitreal ranibizumab or triamcinolone acetonide, administered to
treat diabetic macular edema, on worsening of diabetic retinopathy. Design Exploratory …